Blog

  • 2025 Nine month sales | Givaudan

    2025 Nine month sales | Givaudan

    Ad hoc announcement pursuant to article 53 LR

    “We are very pleased with our continued good sales performance in the first nine months of 2025, against very strong prior year comparables. The natural hedges of Givaudan continue to support our strong performance across business segments, geographies and customer groups, despite the ongoing geopolitical, trade and macroeconomic challenges. Givaudan remains highly focused on supporting our customers’ growth in developing innovative products which consumers love.”

    Gilles Andrier, CEO

    Sales performance

    In the first nine months of 2025 Givaudan recorded sales of CHF 5,743 million, an increase of 5.7% on a like-for-like¹ (LFL) basis and an increase of 1.7% in Swiss francs.

    Givaudan continued the first nine months of the year with good volume growth and maintained its operations and global supply chain at a high level.

    With higher input costs in 2025, including tariffs, the Company is implementing price increases in collaboration with its customers to fully compensate for the increases in input costs.

    The good growth was supported by the 8.1% LFL in the high growth markets, the continued outperformance of local and regional customers across the group and the sustained strong performance of Fine Fragrance.

    Fragrance & Beauty sales were CHF 2,923 million, an increase of 8.0% LFL and an increase of 5.1% in Swiss francs.

    On a business unit basis, Fine Fragrance sales increased by 18.7% LFL against a high prior year comparable growth of 17.8%, and Consumer Products sales increased by 5.9% LFL against a strong prior year comparable growth of 15.9%. Sales of Fragrance Ingredients and Active Beauty increased by 1.5% LFL, with strong double-digit growth in Active Beauty offset by weaker performance in Fragrance Ingredients.

    Taste & Wellbeing sales were CHF 2,820 million, an increase of 3.4% LFL and a decrease of -1.5% in Swiss francs.

    On a regional basis, sales increased in South Asia, Middle East and Africa by 8.8% LFL, in Europe by 3.8% LFL, in North America by 3.9% LFL and in Latin America by 3.1% LFL. Sales decreased in Asia Pacific by -0.5% LFL. Within the product segments, there was broad based good growth in health care, snacks, sweet goods, and in dairy.

    Our mid and long term ambitions

    Our 2025 strategy, ‘Committed to Growth, with Purpose’, is our intention to deliver growth in partnership with our customers, through creating inspiring products for happier, healthier lives and having a positive impact on nature, people and communities.

    Ambitious targets are an integral part of this strategy, with the Company aiming to achieve organic sales growth of 4–5% on a like-for-like basis and free cash flow2 of at least 12%, both measured as an average over the five-year period strategy cycle. In addition, we aim to deliver on key non-financial targets around sustainability, diversity and safety, linked to Givaudan’s purpose.

    With average like-for-like sales growth of 7.2% for the period 2021–2024 and the continued strong like-for-like growth in the first nine months of 2025 of 5.7%, Givaudan is highly likely to exceed the upper end of its average five-year sales growth target of 4–5% on a like-for-like basis for the period 2021–2025.

    Our bold and ambitious long-term purpose goals are defined in four domains: creations, nature, people and communities. Our ambitions include doubling our business through creations that contribute to happier, healthier lives by 2030, becoming climate positive before 2050, becoming a leading employer for inclusion before 2025 and sourcing all materials and services in a way that protects the environment and people by 2030.


    Further information

    Upcoming events
    Full year results – 29 January 2026


    Contact
    Claudia Pedretti, Head of Investor and Media Relations
    T +41 52 354 01 32
    E claudia.pedretti@givaudan.com


    Key tables

    Sales performance for the nine month period ended September

     

    2025

    2024

    January to September
    In millions of Swiss francs

    Group

    Fragrance
    & Beauty

    Taste & 
    Wellbeing

    Group

    Fragrance
    & Beauty

    Taste &
    Wellbeing

    Sales as reported

    5,743

    2,923

    2,820

    5,644

    2,782

    2,862

    – growth in CHF (%)

    1.7%

    5.1%

    -1.5%

    7.2%

    10.8%

    3.9%

    like-for-like¹ (%)

    5.7%

    8.0%

    3.4%

    13.0%

    15.6%

    10.7%

    Acquisition impact (net) (a)

    41

    42

    -1

    17

    26

    -9

    – acquisition impact (net) (%)

    0.7%

    1.5%

    0.0%

    0.3%

    1.0%

    -0.3%

    Currency effects

    -262

    -123

    -139

    -324

    -146

    -178

    – currency effects (%)

    -4.7%

    -4.4%

    -4.9%

    -6.1%

    -5.8%

    -6.5%

    (a) Acquisitions and divestments

     

    2025

    2024

    January to September
    In millions of Swiss francs

    Group

    Fragrance
    & Beauty

    Taste &
    Wellbeing

    Group

    Fragrance
    & Beauty

    Taste &
    Wellbeing

    Acquisitions and divestments

    41

    42

    -1

    17

    26

    -9

    – Vollmens

    2

    2

     

     

     

     

    – b.kolor

    40

    40

     

    20

    20

     

    – Amyris

     

     

     

    6

    6

     

    – Discontinued and disposed business

    -1

     

    -1

    -9

     

    -9

    Sales performance for the three month period ended September

     

    2025

    2024

    Quarter only
    In millions of Swiss francs

    Group

    Fragrance 
    & Beauty

    Taste & 
    Wellbeing

    Group

    Fragrance 
    & Beauty

    Taste & 
    Wellbeing

    Sales as reported

    1,879 

    968 

    911

    1,907 

    956 

    951

    – growth in CHF (%)

    -1.5%

    1.3%

    -4.3%

    10.2%

    13.9%

    6.8%

    – like-for-like¹ (%)

    4.4%

    6.8%

    2.1%

    14.1%

    16.0%

    12.4%

    Acquisition impact (net) (b)

    2

    2

     

    19 

    20

    -1

    – acquisition impact (net) (%)

    0.1%

    0.2%

    0.0%

    1.1%

    2.4%

    -0.1%

    Currency effects

    -115

    -55

    -60

    -87

    -37

    -50

    – currency effects (%)

    -6.0%

    -5.7%

    -6.4%

    -5.0%

    -4.5%

    -5.5%

    (b) Acquisitions and divestments

     

    2025

    2024

    Quarter only
    In millions of Swiss francs

    Group

    Fragrance 
    & Beauty

    Taste & 
    Wellbeing

    Group

    Fragrance 
    & Beauty

    Taste & 
    Wellbeing

    Acquisitions and divestments

    2

    2

     

    19

    20

    -1

    – Vollmens

    2

    2

     

     

     

     

    – b.kolor

     

     

     

    20

    20

     

    – Discontinued and disposed business

     

     

     

    -1

     

    -1

    Sales performance by business activity

     

    2025

    2024

    January to September
    in %

    Sales growth LFL¹

    Sales growth LFL¹

    Fragrance & Beauty

    8.0%

    15.6%

    – Fine Fragrance

    18.7%

    17.8%

    – Consumer Products

    5.9%

    15.9%

    – Fragrance Ingredients and Active Beauty

    1.5%

    10.8%

    Taste & Wellbeing

    3.4%

    10.7%

    – Europe

    3.8%

    6.3%

    – South Asia, Middle East and Africa

    8.8%

    17.9%

    – North America

    3.9%

    5.1%

    – Latin America

    3.1%

    28.9%

    – Asia Pacific

    -0.5%

    10.1%

    Sales performance by geography

     

    2025

    2024

    January to September
    In millions of Swiss francs

    Sales
    reported

    LFL¹ %

    CHF %

    Sales
    reported

    LFL¹ %

    CHF %

    LATAM

    643

    5.7%

    -4.3%

    672

    29.5%

    5.7%

    APAC

    1,366

    4.6%

    -0.5%

    1,373

    12.1%

    7.0%

    NOAM

    1,328

    3.5%

    0.3%

    1,323

    5.7%

    3.9%

    EAME

    2,406

    7.6%

    5.7%

    2,276

    13.1%

    9.8%

    High growth markets

    2,787

    8.1%

    6.5%

    2,618

    20.9%

    10.5%

    Mature markets

    2,956

    3.4%

    -2.4%

    3,026

    6.6%

    4.5%

    Total Group

    5,743

    5.7%

    1.7%

    5,644

    13.0%

    7.2%

    Continue Reading

  • China’s space probe which is halfway to asteroid grabs stunning selfie as Earth glows tiny in the background

    China’s space probe which is halfway to asteroid grabs stunning selfie as Earth glows tiny in the background

    Move over, Ellen DeGeneres’ famous 2014 Oscars selfie, there’s a new player in town – China’s space probe, which is halfway to an asteroid, grabbed a stunning selfie in front of Earth as it glows tiny in the…

    Continue Reading

  • 6 tips to manage winter asthma effectively: Prevent flare-ups and protect lung health |

    6 tips to manage winter asthma effectively: Prevent flare-ups and protect lung health |

    Asthma is a chronic respiratory condition in which inflammation and narrowing of the airways make breathing difficult. During winter, symptoms often worsen due to cold air, dry indoor environments, respiratory infections, and increased exposure…

    Continue Reading

  • From Texas lift-off to Indian Ocean splashdown: Elon Musk’s SpaceX Starship completes 11th test flight- watch

    From Texas lift-off to Indian Ocean splashdown: Elon Musk’s SpaceX Starship completes 11th test flight- watch

    Starship test flight launch

    SpaceX conducted another test flight of its massive Starship rocket on Monday, successfully completing half a global journey while deploying mock satellites as in the previous mission.The world’s largest and most…

    Continue Reading

  • Crashes From Space Are Getting More Common, And No One’s Sure What To Do About It

    Crashes From Space Are Getting More Common, And No One’s Sure What To Do About It

    Just in May of this year, the Soviets struck a ground target from orbit. Never mind that they didn’t intend to; in fact, never mind that there are no ‘Soviets’ anymore. A piece of Cosmos 482, a rocket intended for Venus that broke up during…

    Continue Reading

  • A single protein could stop sudden death after heart attacks

    A single protein could stop sudden death after heart attacks

    Nina Kumowski, MD, of the Department of Radiology and Center for Systems Biology at Massachusetts General Hospital, is the lead author and Matthias Nahrendorf, MD, PhD of the Department of Radiology and Center for Systems Biology at MGH, is the…

    Continue Reading

  • PTSD following sexual assault linked to profound fronto-limbic brain changes

    PTSD following sexual assault linked to profound fronto-limbic brain changes

    Around 70% of women who suffer a sexual assault develop PTSD; now scientists have shown that many of these women show a marked reduction in the usual communication between two important brain areas involved in processing and control…

    Continue Reading

  • Scientists Uncover the Brain’s Hidden Pain Switch – SciTechDaily

    1. Scientists Uncover the Brain’s Hidden Pain Switch  SciTechDaily
    2. A parabrachial hub for need-state control of enduring pain  Nature
    3. Hunger, Fear, and the Brain’s Hidden Switch to Turn Off Chronic Pain  Neuroscience News
    4. Scientists discover brain…

    Continue Reading

  • Ultraviolet light helps growers put fungicides to bed in new R&D project | News

    Ultraviolet light helps growers put fungicides to bed in new R&D project | News

    A new Australian research project is aiming to replace chemical fungicides with ultraviolet light in the fight against powdery mildew – a disease that can wipe out up to 30 per cent of strawberry crops each year.

    The four-year initiative,…

    Continue Reading

  • Anesthesiologist-led care speeds surgery and reduces complications for hip fracture patients

    Anesthesiologist-led care speeds surgery and reduces complications for hip fracture patients

    When anesthesiologists lead the preoperative process, patients undergoing surgery for hip fractures – one of the leading causes of hospitalization in older adults – get to the operating room (OR) faster and have fewer complications,…

    Continue Reading